Alembic Pharmaceuticals Confirms Demise of Resident Director Saibal Mukherjee
Alembic Pharmaceuticals Ltd announced the demise of its Resident Director (Delhi Office), Mr. Saibal Mukherjee. The director's passing was confirmed on April 26, 2026.Mr. Saibal Mukherjee was an integral part of the organization, having joined Alembic Pharmaceuticals in 2014. The company noted that his unexpected demise represents an irreparable loss to the firm and its employees.
The primary details regarding the change in directorship are as follows:
| Particulars | Detail |
|---|---|
| Role | Resident Director (Delhi Office) |
| Name | Mr. Saibal Mukherjee |
| Reason for Change | Demise |
| Date of Demise | April 26, 2026 |
The company paid its deepest sympathies and condolences to Mr. Saibal Mukherjee's family following the passing.
APLLTD Stock Price Movement
Shares of Alembic Pharmaceuticals Limited are rallying higher to ₹768.15 as of 12:27 PM today, gaining 2.28% on the day. This strong performance is supported by notable liquidity, with the equity trading a total volume of 100,344 shares in the live market.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.